Weight Loss

We specialize in offering personalized weight loss management solutions that combine cutting-edge medication with tailored physical activity and diet plans to achieve lasting results.

Recognizing that weight loss is not a one-size-fits-all endeavor,

Dr. Suastegui and our team of providers are dedicated to customizing treatment plans for each individual

We offer a range of researched medications, including:

Semaglutide (Ozempic)
Tirzepatide (Mounjaro)
Sermorelin
Naltrexone
Wellbutrin

Through a comprehensive approach that addresses both medical and lifestyle factors, we empower our patients to achieve their weight loss goals effectively and sustainably.

Semaglutide

Also known as Wegovy, Ozempic, Rybelsus

Description

Semaglutide, a GLP-1 receptor agonist. It was FDA approved in 2021. It is administered as an injection and approved for use in adults and children aged 12 years or more with obesity (BMI ≥30 for adults, BMI ≥ 95th percentile for age and sex for children) or some adults with excess weight (BMI ≥27) (overweight) who also have weight-related medical problems. The dose must be increased gradually over 16 to 20 weeks. This progression can help to alleviate side effects.

How it Works

GLP-1 works to increase insulin levels by activating cells in the pancreas. It also triggers hormone release to delay the emptying of the stomach.

Expected Results

When used alongside robust lifestyle management (200 min exercise/week, nutri-system diet, bimonthly nutritionist visits) patients observed 10-14% weight loss, maintained over 2 years.

Liraglutide

Also known as Saxenda / Victoza

Description

Liraglutide is a GLP-1 agonist medication, very similar to Semaglutide. It was initially developed as a medication for Type 2 Diabetes but found to also help patients with weight loss.

By activating GLP-1 receptors, this medication works to slow the rate at which your stomach empties, and to send signals to your brain to decrease appetite.

How it Works

GLP-1 works to increase insulin levels by activating cells in the pancreas. It also triggers hormone release to delay the emptying of the stomach.

Expected Results

Trials showed patients can lose 6.2% over 52 weeks.

Tirzepatide

Also known as Mounjaro, Zepbound

Description

Tirzepatide was previously approved to treat type 2 diabetes as Mounjaro.

As Zepbound, it is approved to treat obesity in adults with a BMI of 30 or greater.

How it Works

It is both a GLP-1 and a GIP receptor agonist and, like semaglutide, works by reducing appetite and is meant to be used in combination with diet and exercise to lose weight. It is also administered as an injection.

Expected Results

Expected weight loss of 22.5%. Additional trials have shown this medication is twice as effective as Semaglutide.

Phentermine

Also known as Adipex / Suprenza

Description

Phentermine is the oldest and most widely used weight loss medication. It was originally used as a short-term medication to jump-start weight loss, but now newer medical guidelines have added it to long-term therapy. Some patients may lose about 5% of their body weight by taking phentermine.

How it Works

The primary mechanism of phentermine's action in treating obesity is the reduction of hunger perception, which is a cognitive process mediated primarily through the hypothalamus. Outside the brain, phentermine releases norepinephrine and epinephrine – also known as noradrenaline and adrenaline respectively – causing fat cells to break down stored fat as well. In the US, phentermine is almost exclusively available in the HCl formulation.

Expected Results

Patients will lose 3% of their initial body weight in three months and 5-7% after six months. It is important to note that everybody responds differently to this medication.

Naltrexone-Bupropion

Also known as Wellbutrin XL, Wellbutrin SR, Forfivo XL, Contrave / Zyban / Aplenzin

Description

Naltrexone-Bupropion combines an opioid receptor antagonist with an antidepressant to affect the pleasure-reward areas of the brain and thereby decrease cravings and appetite. Some patients may lose 5–10% of body weight.

How it Works

Bupropion works by inhibiting neurotransmitter reuptake of norepinephrine and dopamine. By holding higher concentrations of these in the brain, neurons increase signaling and alter hunger and mood.

Expected Results

Bupropion has been studied extensively, both independently and in conjunction with Naltrexone (Contrave). The COR-I, COR-II, COR-BMOD, and COR-Diabetes trials demonstrated 8.1-11.5% weight loss over 2 years.

Topiramate

Also known as Topamax / Qudexy / Trokendi XR

Description

Topiramate, a medication originally created to treat epilepsy, was approved by the FDA in 1998. It is used off-label for weight loss, often in conjunction with Phentermine. It can be used short- or long-term for weight loss safely.

How it Works

Topiramate alters a variety of GABA and Glutamate channels by blocking voltage-gated sodium channels decreasing glutamine in the brain to suppress cravings and appetite.

Expected Results

Topiramate has independently shown results in meta-analysis of 5.34kg weight loss. In conjunction with Phentermine, the CONQUER and SEQUEL Trials showed as high as 10.7% weight loss in low-dose and 14% in high-dose groups maintained over 2 years.

Set Appointment

Weight Loss

FOLLOW US

LinkedIn

CONTACT US

Visit our office
4161 NW 5th St,
Suite 201,
Plantation,
FL 33317

Call us
Main: +1 (954) 859 - 6051
Fax: +1 (954) 349 - 1716

Email us
admin@evolvewellrec.com

Weight Loss

FOLLOW US

LinkedIn

CONTACT US

Visit our office 4161 NW 5th St, Suite 201, Plantation, FL 33317 Call us Main: +1 (954) 859 - 6051 Fax: +1 (954) 349 - 1716 Email us admin@evolvewellrec.com

Visit our office
4161 NW 5th St,
Suite 201,
Plantation,
FL 33317

Call us
Main: +1 (954) 859 - 6051
Fax: +1 (954) 349 - 1716

Email us
admin@evolvewellrec.com